LEONARD D. SCHAEFFER - 26 Aug 2024 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
Director
Signature
/s/ John H. Tucker, attorney-in-fact
Issuer symbol
SCPH
Transactions as of
26 Aug 2024
Net transactions value
+$29,308
Form type
4
Filing time
28 Aug 2024, 16:30:14 UTC
Previous filing
13 Jun 2024
Next filing
05 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPH Common Stock Options Exercise $8,670 +5,223 +12% $1.66 48,327 26 Aug 2024 Direct
transaction SCPH Common Stock Options Exercise $20,638 +6,124 +13% $3.37 54,451 26 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (Right to Buy) Options Exercise $0 -5,223 -100% $0.000000 0 26 Aug 2024 Common Stock 5,223 $1.66 Direct F1
transaction SCPH Stock Option (Right to Buy) Options Exercise $0 -6,124 -100% $0.000000 0 26 Aug 2024 Common Stock 6,124 $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested.